Hochschulschrift
The protective effect of the Wnt inhibitor sclerostin in inflammatory bone destruction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
IX, 86 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen
Westfälische Wilhelms-Universität Münster, Dissertation, 2020
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:47 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2020
Other Objects (12)
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
The role of Wnt inhibitor sclerostin in rheumatoid arthritis
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Identification of Repurposed FDA Drugs by Targeting Sclerostin via the Wnt Pathway for Alveolar Bone Formation
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
Sclerostin Inhibition in the Management of Osteoporosis
Sclerostin and Cardiovascular Disease
Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
The role of Wnt inhibitor sclerostin in rheumatoid arthritis
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Identification of Repurposed FDA Drugs by Targeting Sclerostin via the Wnt Pathway for Alveolar Bone Formation
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
Sclerostin Inhibition in the Management of Osteoporosis
Sclerostin and Cardiovascular Disease
Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
The role of Wnt inhibitor sclerostin in rheumatoid arthritis
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Identification of Repurposed FDA Drugs by Targeting Sclerostin via the Wnt Pathway for Alveolar Bone Formation
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
Sclerostin Inhibition in the Management of Osteoporosis
Sclerostin and Cardiovascular Disease
Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome